Back to Agenda
Session 2 : Advancing Pharmacovigilance: regulatory use of database and Risk Management Plan
Session Chair(s)
Min-Jung Lim, MPHARM, RPH
CEO & Senior Pharmacovigilance Consultant
MediSafe, Pharmacovigilance Services, Korea, Republic of
In-sook Park, PHD
Director General
Korean Regulatory Science Center, Korea, Republic of
Speaker(s)
Session 2 - 1
Takashi Waki, PHD, RPH
Pharmaceuticals and Medical Devices Agency, Japan
Epidemiologist
Session 2 - 2
Bonggi Kim, PHD
Korea Institute of Drug Safety and Risk Management, Korea, Republic of
Director
Session 2 - 3
Jingyu (Julia) Luan, PHD
AstraZeneca, United States
Executive Regulatory Science Director, BioPharmaceuticals R&D
Ju-Young Shin, PHARMD, PHD
School of Pharmacy, Sungkyunkwan University, Korea, Republic of
Professor
Hyungjin Jung, MD, MBA
Lundbeck Korea, Korea, Republic of
Senior Medical Director
Younglim Kim, PHD
National Institute of Food & Drug Safety (NIFDS), Korea, Republic of
Director General
Nam-Kyong Choi, PHD
Seoul National University College of Medicine/Seoul National University Hospital, Korea, Republic of
Research Professor, Division of Clinical Epidemiology
Have an account?